BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen ZX, Chen YL, Huang XM, Lin XT, He XW, Lan P. Risk factors for recurrence after bowel resection for Crohn’s disease. World J Gastrointest Pharmacol Ther 2019; 10(4): 67-74 [PMID: 31692953 DOI: 10.4292/wjgpt.v10.i4.67]
URL: https://www.wjgnet.com/2150-5349/full/v10/i4/67.htm
Number Citing Articles
1
Wei-Song Shen, Xiao-Hui Huang, Rui-Qing Liu, Chen-Yang Li, Yi Li, Wei-Ming Zhu. Perforating and nonperforating indications in repeated surgeries for Crohn’s diseaseWorld Journal of Clinical Cases 2022; 10(9): 2733-2742 doi: 10.12998/wjcc.v10.i9.2733
2
Wei-Song Shen, Xiao-Hui Huang, Rui-Qing Liu, Chen-Yang Li, Yi Li, Wei-Ming Zhu. Perforating and nonperforating indications in repeated surgeries for Crohn’s diseaseWorld Journal of Clinical Cases 2022; 10(9): 2731 doi: 10.12998/wjcc.v10.i9.2731
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
3
Javier P. Gisbert, María Chaparro. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s DiseaseDrugs 2023; 83(13): 1179 doi: 10.1007/s40265-023-01916-2
4
A. V. Poletova, M. V. Shapina. Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrenceMeditsinskiy sovet = Medical Council 2020; (15): 128 doi: 10.21518/2079-701X-2020-15-128-133
5
Enhao Wu, Ming Duan, Jianqiu Han, Hanzhe Zhang, Yan Zhou, Lei Cao, Jianfeng Gong, Zhen Guo, Yi Li, Weiming Zhu. Patients with Crohn's Disease Undergoing Abdominal Surgery: Clinical and Prognostic Evaluation Based on a Single‐Center Cohort in ChinaWorld Journal of Surgery 2022; 46(2): 450 doi: 10.1007/s00268-021-06366-z